Evidence map›Paper›PMID 33312338›Full record

ReviewOxidative medicine and cellular longevity2020

NOX2-Derived Reactive Oxygen Species in Cancer.

Hanna Grauers Wiktorin, Ebru Aydin, Kristoffer Hellstrand, Anna Martner

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Androsin alleviates colorectal cancer by inhibiting the PI3K/Akt-centered signaling pathway.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. NOX Family: Regulators of Reactive Oxygen Species Balance in Tumor Cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Hanna Grauers WiktorinTIMM Laboratory, Salgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicin, Sahlgrenska Academy, University of Gothenburg, Sweden.
Ebru AydinTIMM Laboratory, Salgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicin, Sahlgrenska Academy, University of Gothenburg, Sweden.
Kristoffer HellstrandTIMM Laboratory, Salgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicin, Sahlgrenska Academy, University of Gothenburg, Sweden.
Anna MartnerTIMM Laboratory, Salgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicin, Sahlgrenska Academy, University of Gothenburg, Sweden.ORCID https://orcid.org/0000-0002-6598-5221
University of Gothenburg · SEGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The formation of reactive oxygen species (ROS) by the myeloid cell NADPH oxidase NOX2 is critical for the destruction of engulfed microorganisms. However, recent studies imply that ROS, formed by NOX2

Indexed as

CarcinogenesisLeukemiaMutationNADPH Oxidase 2Neoplasm ProteinsReactive Oxygen SpeciesTumor MicroenvironmentAnimalsHumansKiller Cells, NaturalLymphocytes, Tumor-InfiltratingMyeloid CellsT-LymphocytesCYBB protein, humanNADPH Oxidase 2Neoplasm ProteinsReactive Oxygen Species

Identifiers

PMID33312338
PMCPMC7721506
OpenAlexW3106851069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.